Stocktoria
Kraig Biocraft Laboratories, Inc. KBLB
Kraig Biocraft Laboratories, Inc. (KBLB) earns a Piotroski F-score of 3/9 (weak financial health). It does not currently pay a dividend.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
How it ranks in Manufacturing · percentile among 2036 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 3/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| KBLB | Kraig Biocraft Laboratories, Inc. | 3/9 | — | — | — |
| CTA-PA | EIDP, Inc. | 7/9 | — | — | -2.1% |
| CE | Celanese Corp | 4/9 | 2.12 | — | -7.1% |
| VFS | VinFast Auto Ltd. | 4/9 | -13.01 | — | +57.9% |
| TM | TOYOTA MOTOR CORP/ | 7/9 | 2.55 | — | -1% |
| HMC | HONDA MOTOR CO LTD | 6/9 | 2.79 | — | +19.9% |
| SONY | Sony Group Corp | 6/9 | 0.86 | — | +9% |
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. develops protein-based fibers using recombinant DNA technology for commercial applications in the textile and specialty fiber industries in the United States. The company's primary proprietary fiber technology includes natural and engineered variants of spider silk produced in domesticated mulberry silkworms, as well as uses genetically engineered silkworms that produce spider silk proteins to create its recombinant spider silk. Its products are used in performance apparel, workwear, filtration, luxury fashion, flexible composites, medical implants, cosmetics, and other applications; and military and police for its ballistic protection. Kraig Biocraft Laboratories, Inc. was incorporated in 2006 and is headquartered in Ann Arbor, Michigan.
FAQ
Is KBLB financially healthy?
Kraig Biocraft Laboratories, Inc.'s Piotroski F-score is 3/9 (8–9 is excellent, 0–3 weak).
Does KBLB pay a dividend?
No, Kraig Biocraft Laboratories, Inc. does not currently pay a dividend.
Is KBLB a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Kraig Biocraft Laboratories, Inc.: a Piotroski F-score of 3/9. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.